XT
COYA icon

XTX Topco’s Coya Therapeutics COYA Stock Holding History

XTX Topco’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$187K Buy
47,338
+14,268
+43% +$66.7K ﹤0.01% 2868
2025
Q4 		$192K Buy
+33,070
New +$201K 0.01% 2420
2025
Q1 		– Sell
-10,299
Closed -$59K – 2511
2024
Q4 		$59K Buy
+10,299
New +$70.2K ﹤0.01% 1870

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

XTX Topco's COYA Position: Q1 2026 in Review

XTX Topco increased its Coya Therapeutics (COYA) stake by 43% in Q1 2026, buying an estimated $66.7K and bringing the position to 47,338 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #2868.

XTX Topco first reported a position in COYA in Q4 2024 and has held it in 3 quarters since. The position peaked at $192K in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • XTX Topco held 47,338 shares of Coya Therapeutics worth $187K as of Q1 2026.
  • XTX Topco bought 14,268 Coya Therapeutics shares in Q1 2026, an estimated $66.7K.
  • Coya Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2868 holding.
  • XTX Topco first reported a position in Coya Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • XTX Topco's Coya Therapeutics position peaked at $192K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.